DR HealthCare USA Migraine


Published on

Published in: Health & Medicine
1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

DR HealthCare USA Migraine

  2. 2.  About Migraine  About Histamine
  3. 3.  About Migraine <ul><li> Migraine is more than a simple headache. It’s an illness. </li></ul><ul><li>The prevalence of the migraine pathology, according to credible sources such as the World Health Organization (WHO), International Headache Society (HIS) and the European Headache Alliance (EHS), is approximately 16% of the general population (more than 1 billion people). Of these, 75% are women between the ages of 15-65 </li></ul><ul><li> 65% of MIGRAINE sufferers feel abandoned by health institutions </li></ul>
  4. 4. Society doesn’t give importance that MIGRAINE deserve, associating it with a simple headache, and resignation arises. However, it’s an illness that affects the family, social and economic life of those who suffer. It significantly alters sufferers lifes within and beyond the work sphere and greatly affects their quality of life. Source: International Headache Society  About Migraine - Much more than a simple headache
  5. 5. In desperation, resigned Migraine Sufferers look for solutions on their own, and the doctors are who learn from them... Learning from Migraine sufferers  About Migraine – A desperate research
  6. 6. . <ul><li> These billion people anxious for pain relief are the primary target market for Migracalm and Migratest. </li></ul><ul><li>According to studies by the University of Barcelona and DR Healthcare, at least 50% of migraine sufferers have a serious deficit of DAO . This half billion people are the target market for Migrasin. </li></ul><ul><li> Up till now, all the therapeutic arsenal has been based on pharmacological treatment proven to be inefficient and dangerous due to the fact that excess medication provokes the cronification of the illness and provides little relief. For this reason the new biofunctional protocol is a unique opportunity. </li></ul> About Migraine – Prevalence and Market
  7. 7. Histamine, a molecule present in all living creatures and in food, is a vital substance for the body. It is present in all food products but in different proportions. Thus, histamine is necessary for life . However, histamine can accumulate excessively and have negative effects. On the other hand, it is also naturally present in many food products. Consumption of such food is harmless, as the histamine they contain can be quickly broken down and processed by the enzyme DiAminoOxidase (DAO), which occurs in the body.  About Histamine
  8. 8. Food histaminosis is quite simply an imbalance of histamine and the enzyme DAO in the body. The deficiency of DAO activity means that the body is not in the position to breakdown ingested histamine quickly enough.     Ingested histamine is broken down significantly more slowly and accumulates within the body. The body then reacts to the accumulated histamine with side effects, the most incapacitant is the migraine.    About Histamine - What is histaminosis? CH 2 -COOH N N- CH 3 Àc.N-metilimidazol acètic H + CO 2 Histidina descarboxilasa CH 2 -CH-NH 2 -COOH CH 2 -CH 2 -NH 2 N N H DAO HMT Histamine CH 2 -CHO N N H CH 2 -COOH N N- Ribosa CH 2 -CHO N N H ADH Àc. Imidazolacètic Ribòsit Ac. Imidazolacètic N-imidazol acetilaldehid CH 2 -CH 2 -NH 2 N N- CH 3 N-metilhistamina N-metilimidazol acetaldehid CH 2 -CHO N N- CH 3 DAO ADH
  9. 9. M. Pfisterer, C. Wennemer, K. Fiedler, A. Missbichler. Diagnose and Treatment of Histamin intolerance, XXVI FAACI Congress. Göteborg. Sweden. 2007  About Histamine – DAO vs Symptoms
  10. 10.  About Histamine – Biogenic amines in food pH optimum is betwen 5 and 6 The lower the temperature, the slower the production of amines Silla Santos M.H Int J. Food Microbiol 29 (1996) 213-231
  11. 11. High concentrations of biogenic amines saturates DAO activity  About Histamine – Inhibition of DAO
  12. 12. 1 Pellet encapsulate DAO degrades approx. 40 ng / ml (39.2 ± 2.3) Histamine. The increases of the in taking of DAO, results in a linear increase in the degradation of histamine (R2 = 0.995 and R2 = 0.985).  About Histamine - Degradation
  13. 13. Small Intestine Receptors DAO Histamine Putrescine Cadaverine Tyramine Serotonine Biogenic Amines Degradation products are easily metabolised Enzyme Deficiency MIGRAINE AND OTHER SYMPTOMS  About Histamine – DAO deficiency
  14. 14. Too much histamine ingested through Eating too much food containing histamine Too little DAO Ingesting substances that block DAO
  15. 15. Histamine is formed from histidine. From a nutritional perspective, histidine is considered one of the nine essential amino acids. Eggs, cheese, milk, beef, chicken, pork, bacon, venison, fish, beef, cod, soy protein, banana, mustard seeds, seaweed, cottonseed meal, sesame seeds sunflower seeds, and yeast are examples of foods that contain a relatively high amount of histidine It is not a good idea to solve the problem of histamine only by reducing the consumption of histidine. HISTIDINE is involved in much more than the production of histamine. To give just one example, histidine is essential for the stabilization of the oxygen binds to hemoglobin in iron ions. In other words without HISTIDINE , the red blood cells would not be able to carry oxygen to the tissues in the body .  About Histamine - What can happen if we make a diet low in histamine?
  16. 16. 41,2% Migraine sufferers with other symptoms of histamine DAO activity value in migraine sufferers 33,8% 41,2% 20,0% 5% Clinical Study – Barcelona University, 2010 DiAmine Oxidasa deficit in Migraine sufferers 48,8% of migraine sufferers, presented values of very low DAO activity, and 46% had values of reduced activity. 95% of migraine sufferers also experience other symptoms related to histaminosis. The average value obtained for DAO activity is lower among the group of migraine sufferers, with a significant difference observed (p = 0.001) 46% 48,2% 5.2%
  17. 17. 1.- Déficit de DAO como posible desencadenante de migraña. Estudio Migradao. Mayo de 2010, Jornada Internacional de Sensibilización sobre la Migraña. Congreso de los Diputados de España 1.C. Vidal, Catedrática de Nutrición y Bromatología de la Universidad de Barcelona, 2.F. Titus, Miembro de Honor de la Sociedad Española de Neurología, 3. Asociación Española de Pacientes con Cefalea (AEPAC), 4.- Dpt. Epidemiología del Colegio de Farmacéuticos de Barcelona. 2.- Supplementation of enteric coated Diamine Oxidase improves intestinal degradation of food-born biogenic amines in case of histamine intolerance. 2010 - March, 6th Annual Conference of the ENA in Vienna. A. Missbichler1, I. Mayer1, C. Pongracz2, F. Gabor3 and P. Komericki 1 Sciotec Diagnostic Technologies, Tulln, Austria. 2 Dept. of Nutritional Sciences, University of Vienna, Austria 3 Dept. of Pharmaceutical echnology & Biopharmaceutics, University of Vienna, Austria 4 Dept. of environmental Dermatology, Medical University of Graz, Austria. 3.- Histamine and histamine intolerance. 2007 - The American Journal of Clinical Nutrition Laura Maintz 1 and Natalija Novak 1, 1 Department of Dermatology and Allergology, University of Bonn, Germany. 4.- Effects of histamine and diamine oxidase activities on pregnancy: a critical review. 2008 - May 22, European Society of Human Reproduction and Embryology. Laura Maintz 1 , Verena Schwarzer 2 , Thomas Bieber 1 , Katrin van der Ven 2 and Natalija Novak , 1 Department of Dermatology and Allergology, University of Bonn, Germany., 2 Department of Obstetrics and Gynaecology, University of Bonn, Germany 5.- Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. 2005 - November 29, The Journal of Allergy and Clinical Immunology Laura Maintz, MD a - Said Benfadal a , Jean-Pierre Allam, MD a – Tobias Hagemann, MD a – Rolf Fimmers, PhD b and Natalija Novak, MD a Bonn, Germany. a The Department of Dermatology, University of Bonn. b The Department of Medical Biometry, Informatics and Epidemiology, University of Bonn. 6.- Histamine intolerance: a metabolic disease? 2009 - December 12, Birkhäuser Verlag, Basel/Switzerland 2009 H.G. Schwelberger, 1 Molecular Biology Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Austria. Scientific background
  18. 18. 7.- Effectiveness of a prolonged compression of scalp arteries on migraine attacks. June 2006 - Journal of Neurology. Volume 253, number 6 Prof. Carlo Cianchetti & Prof. Jousef Hmaidan. University dpt. Neurosciencies- Cagliari (Italy) 8.- Compression of Superficial Temporal Arteries by a Handmade Device: A Simple Way to Block or attenuate Migraine Attacks in Children and Adolescents. June 2009 – Journal Child Neurology, Volume 25, pp 67-70. Prof. Giussepina Ledda. University dpt. Neuroseciencies – Cagriari (Italy) 9.- Treatment of migraine attacks by compression of temporal superficial arteries using a device. April 2009 -Journal of Neurology. Medical Science Monitor – New York CR 185-8 Prof. Carlo Cianchetti, Prof. Tiziana Pisano, Prof. Elisabeth Cianchetti & Prof. Giussepina Ledda University dpt. Neurosciencies – Cagliari (Italy) 10.-Legal-medical and neurological assessment of its informative distribution as a medical device used to relieve migraines.  May 2008 - Autonomous University of Barcelona-Valle Hebron University Hospital. Ref. 18/08 Prof. Manuel Rodriguez Pazos & Prof. Manuel Romacho Romero. Schhol of Medicine. Autonomous University of Barcelona University Hospital Valle Hebrón. Scientific background (2)
  19. 19. Thank you for your attention